Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

798.84 -27.07 (-3.28%)
Streaming Delayed Price Updated: 3:04 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
According to Direxion CEO Douglas Yones, Eli Lilly and Palo Alto Networks are prime candidates for leveraged trading. 
Via Benzinga
Topics ETFs
Direxion Expands Single Stock Leveraged & Inverse ETF Lineup for Exposure to Eli Lilly & Palo Alto Networks
Extends Leadership Role with First-Ever Palo Alto Networks Trading Pair, Alongside New Pharma Trades 
Via News Direct
Topics ETFs
2 No-Brainer Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
From Organovo, Inc.
Via GlobeNewswire
Eli Lilly Shares Rise Over 2% After Key Signal
A significant trading signal occurred for Eli Lilly stock, as it demonstrated a Power Inflow at $849.02, after which LLY rose up to 2.1% 
Via Benzinga
5 Stocks That Could Be The Next Nvidia
Via Benzinga
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. 
Via The Motley Fool
Eli Lilly Unusual Options Activity
Via Benzinga
Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.
Novo Nordisk is now planning to take on Eli Lilly's experimental retatrutide, a triple agonist for weight loss and diabetes. 
Via Investor's Business Daily
Market Sell-Off: Can Buying These 3 "Safe" Stocks Today Set You Up for Life?
These fundamentally strong stocks remain safer picks, despite the heightened market volatility. 
Via The Motley Fool
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid... 
Via Benzinga
Topics World Trade
Exposures Tariff
Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks
Instead of chasing returns, investors can start building long-term passive income through dividend growth stocks. 
Via Talk Markets
Topics Stocks / Equities
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stock 
Via MarketBeat
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Via The Motley Fool
Eli Lilly Shares Are Up Today: What's Going On?
Eli Lilly & Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in India. 
Via Benzinga
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Via The Motley Fool
3 Market-Beating Stocks to Target This Week
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the... 
Via StockStory
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug. 
Via MarketBeat
Why Hims & Hers Stock Popped on Monday
Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock? 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Via The Motley Fool
Top 10 High Alpha Stocks For Dividend Investors
Most investors are seeking outperformance when buying stocks. One of the most popular measures of investment outperformance is alpha. 
Via Talk Markets
Topics Stocks / Equities
Top gainers and losers in the S&P500 index during Friday's after-hours session.
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers. 
Via Chartmill
What's going on in today's after hours session
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
CVS Weight Management program members achieved 15% average weight loss, with 92% satisfaction and 26% lower GLP-1 medication costs for participating clients. 
Via Benzinga
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss and liver health benefits. 
Via Benzinga
3 Healthcare Stocks with Exciting Potential
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Visa, Eli Lilly, Blackstone And A Real Estate Stock On CNBC's 'Final Trades'
Via Benzinga
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.